Trials / Terminated
TerminatedNCT00616824
The Use of an Acellular Dermal Matrix in a Two-Staged Breast Reconstruction
The Use of an Acellular Dermal Matrix in a Two-Staged Breast Reconstruction The Use of an Acellular Dermal Matrix in a Two-Staged Breast Reconstruction After Mastectomy: A Double-Blinded, Randomized Trial
- Status
- Terminated
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 36 (actual)
- Sponsor
- Vanderbilt University Medical Center · Academic / Other
- Sex
- Female
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study intends to compare postoperative outcomes of a tissue expander placement following a mastectomy with two different operative techniques. This study will be randomized and double blinded comparing the traditional placement of the tissue expander under an inferolateral serratus muscle flap to a new technique which uses an acellular dermal matrix as an inferolateral sling, instead of the muscle flap. The study we are proposing will evaluate the question of whether there is a difference between the traditional method of serratus flap and the new technique of using an acellular matrix with tissue expander placement. This will be a double blinded randomized study of thirty women in each group comparing outcomes which will include postoperative pain, complications (wound infection, hematoma, capsular contracture, etc), and patient satisfaction with the procedure.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| PROCEDURE | Dermamatrix to cover lateral aspect of tissue expander | Dermamatrix used to cover lateral aspect of breast tissue expander after mastectomy |
| PROCEDURE | Serratus anterior to cover lateral aspect of tissue expander | Traditional use of serratus anterior for coverage of lateral aspect of tissue expander |
Timeline
- Start date
- 2007-09-01
- Primary completion
- 2010-03-01
- Completion
- 2010-03-01
- First posted
- 2008-02-15
- Last updated
- 2017-04-04
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT00616824. Inclusion in this directory is not an endorsement.